| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $308.6M | +19.6% |
| Cost of Revenue | $73.1M | +8.8% |
| Gross Profit | $235.6M | +23.5% |
| R&D Expense | $95.1M | +17.4% |
| SG&A Expense | $56.0M | +2.8% |
| Operating Income | -$88.9M | -0.5% |
| Pre-tax Income | -$104.4M | -1.8% |
| Income Tax | $1.2M | +355.7% |
| Net Income | -$105.6M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.5M | -20.4% |
| Accounts Receivable | $79.0M | +23.1% |
| Current Assets | $168.8M | -2.5% |
| Total Assets | $242.1M | -1.0% |
| Current Liabilities | $248.6M | +5.1% |
| Long-term Debt | $108.6M | +4.4% |
| Total Liabilities | $388.5M | +4.8% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.9M | -2973.4% |
| Capital Expenditures | $8.0M | +22.7% |
| Investing Cash Flow | -$8.0M | -22.7% |
| Financing Cash Flow | $2.4M | +532.1% |
| Free Cash Flow | -$18.9M | -207.7% |
| -3.4% |
| EPS (Basic) | -$3.10 | +2.8% |
| EPS (Diluted) | -$3.10 | +2.8% |
| Stockholders' Equity |
| -$146.4M |
| -16.2% |